Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33

The human Sigma1 receptor (S1R), which has been identified as a target with an important role in neuropsychological disorders, was first crystallized 3 years ago. Since S1R structure has no relation with another previous crystallized structures, the presence of the new crystal is an important hallma...

Full description

Bibliographic Details
Main Authors: José Luis Velázquez-Libera, Giacomo Rossino, Carlos Navarro-Retamal, Simona Collina, Julio Caballero
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fchem.2019.00496/full
id doaj-f201896eb2b24e4ba2ad186dfb9c1cd3
record_format Article
spelling doaj-f201896eb2b24e4ba2ad186dfb9c1cd32020-11-25T01:43:07ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462019-07-01710.3389/fchem.2019.00496465769Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33José Luis Velázquez-Libera0Giacomo Rossino1Carlos Navarro-Retamal2Simona Collina3Julio Caballero4Centro de Bioinformática y Simulación Molecular, Facultad de Ingeniería, Universidad de Talca, Talca, ChilePharmaceutical and Medicinal Chemistry Section, Drug Sciences Department, Università di Pavia, Pavia, ItalyCentro de Bioinformática y Simulación Molecular, Facultad de Ingeniería, Universidad de Talca, Talca, ChilePharmaceutical and Medicinal Chemistry Section, Drug Sciences Department, Università di Pavia, Pavia, ItalyCentro de Bioinformática y Simulación Molecular, Facultad de Ingeniería, Universidad de Talca, Talca, ChileThe human Sigma1 receptor (S1R), which has been identified as a target with an important role in neuropsychological disorders, was first crystallized 3 years ago. Since S1R structure has no relation with another previous crystallized structures, the presence of the new crystal is an important hallmark for the design of agonists and antagonists against this important target. Some years ago, our group identified RC-33, a potent and selective S1R agonist, endowed with neuroprotective properties. In this work, drawing on new structural information, we studied the interactions of RC-33 and its analogs with the S1R binding site by using computational methods such as docking, interaction fingerprints, and receptor-guided alignment three dimensional quantitative structure–activity relationship (3D-QSAR). We found that RC-33 and its analogs adopted similar orientations within S1R binding site, with high similitude with orientations of the crystallized ligands; such information was used for identifying the residues involved in chemical interactions with ligands. Furthermore, the structure-activity relationship of the studied ligands was adequately described considering classical QSAR tests. All relevant aspects of the interactions between the studied compounds and S1R were covered here, through descriptions of orientations, binding interactions, and features that influence differential affinities. In this sense, the present results could be useful in the future design of novel S1R modulators.https://www.frontiersin.org/article/10.3389/fchem.2019.00496/fullsigma1 receptor ligandsRC-33arylalkylamine derivatesdockingquantitative structure–activity relationshipsinteraction fingerprints
collection DOAJ
language English
format Article
sources DOAJ
author José Luis Velázquez-Libera
Giacomo Rossino
Carlos Navarro-Retamal
Simona Collina
Julio Caballero
spellingShingle José Luis Velázquez-Libera
Giacomo Rossino
Carlos Navarro-Retamal
Simona Collina
Julio Caballero
Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33
Frontiers in Chemistry
sigma1 receptor ligands
RC-33
arylalkylamine derivates
docking
quantitative structure–activity relationships
interaction fingerprints
author_facet José Luis Velázquez-Libera
Giacomo Rossino
Carlos Navarro-Retamal
Simona Collina
Julio Caballero
author_sort José Luis Velázquez-Libera
title Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33
title_short Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33
title_full Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33
title_fullStr Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33
title_full_unstemmed Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure–Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33
title_sort docking, interaction fingerprint, and three-dimensional quantitative structure–activity relationship (3d-qsar) of sigma1 receptor ligands, analogs of the neuroprotective agent rc-33
publisher Frontiers Media S.A.
series Frontiers in Chemistry
issn 2296-2646
publishDate 2019-07-01
description The human Sigma1 receptor (S1R), which has been identified as a target with an important role in neuropsychological disorders, was first crystallized 3 years ago. Since S1R structure has no relation with another previous crystallized structures, the presence of the new crystal is an important hallmark for the design of agonists and antagonists against this important target. Some years ago, our group identified RC-33, a potent and selective S1R agonist, endowed with neuroprotective properties. In this work, drawing on new structural information, we studied the interactions of RC-33 and its analogs with the S1R binding site by using computational methods such as docking, interaction fingerprints, and receptor-guided alignment three dimensional quantitative structure–activity relationship (3D-QSAR). We found that RC-33 and its analogs adopted similar orientations within S1R binding site, with high similitude with orientations of the crystallized ligands; such information was used for identifying the residues involved in chemical interactions with ligands. Furthermore, the structure-activity relationship of the studied ligands was adequately described considering classical QSAR tests. All relevant aspects of the interactions between the studied compounds and S1R were covered here, through descriptions of orientations, binding interactions, and features that influence differential affinities. In this sense, the present results could be useful in the future design of novel S1R modulators.
topic sigma1 receptor ligands
RC-33
arylalkylamine derivates
docking
quantitative structure–activity relationships
interaction fingerprints
url https://www.frontiersin.org/article/10.3389/fchem.2019.00496/full
work_keys_str_mv AT joseluisvelazquezlibera dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33
AT giacomorossino dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33
AT carlosnavarroretamal dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33
AT simonacollina dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33
AT juliocaballero dockinginteractionfingerprintandthreedimensionalquantitativestructureactivityrelationship3dqsarofsigma1receptorligandsanalogsoftheneuroprotectiveagentrc33
_version_ 1725033139201376256